Zoetis, Inc. (ZTS)
122.23
-3.73
(-2.96%)
USD |
NYSE |
Mar 05, 16:00
122.00
-0.23
(-0.19%)
Pre-Market: 07:59
Zoetis Cash from Investing (Quarterly) : -166.00M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Elanco Animal Health, Inc. | -64.00M |
| Bristol Myers Squibb Co. | -1.458B |
| Johnson & Johnson | -4.485B |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Moderna, Inc. | -48.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 893.00M |
| Cash from Financing (Quarterly) | -495.00M |
| Free Cash Flow | 2.283B |
| Free Cash Flow Per Share (Quarterly) | 1.669 |
| Free Cash Flow to Equity (Quarterly) | -1.292B |
| Free Cash Flow to Firm (Quarterly) | 781.13M |
| Free Cash Flow Yield | 4.21% |